You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Myriad Genetics' EndoPredict, Agendia's MammaPrint (distributed in Germany by PathoNext), and Veracyte's Prosigna will now be covered by public insurance.
As government lab spending grows, the Medicare contractor has barred access to a coding and pricing file obtained via FOIA claiming it holds business secrets.
News items for in vitro diagnostics industry for the week of August 17, 2020.
The firm reported total revenues of $93.2 million, down from $215.4 million in fiscal Q4 2019 and short of the consensus Wall Street estimate of $93.9 million.
In a local coverage article, Medicare contractors in the MolDx program added prostate cancer to the covered indications for the test.
News items for the in vitro diagnostics industry for the week of July 6, 2020
Of the 28 companies in the index, 21 firms saw their stock prices increase throughout the first half of the year, while seven firms' share prices decreased.
Of the 28 companies in the index, 18 firms saw their stock prices increase, while 10 firms' share prices decreased.
News items for the in vitro diagnostics industry for the week of June 15, 2020.
Under the LCD, pharmacogenomic tests are covered when medications are being considered for use that are known to have a clinically actionable gene-drug interaction.